Semifinals
If at first you don't succeed...try again
Embedded Files
Denmark: SGLT2i in kidney stone prevention
Denmark: SGLT2i in kidney stone prevention
In a remarkable match that saw England and IV iron maintain its lead for most of the match, Denmark pulled out a victory on the last day of voting. IV iron to prevent MI in HD patients has a lot of positives going for it, but this is the year of the SGLT2i.
It's now a clash of SGLT2i and indications. Denmark enters the NephroWorldCup Championship match riding high and with momentum, but can it overcome the pure dominance of Spain in this year's Tournament?
Spain: SGLT2i + MRA to reduce albuminuria
Spain: SGLT2i + MRA to reduce albuminuria
Surprise surprise. Spain returns to the NephroWorldCup Championship match. After winning the 2018 NephroWorldCup Tournament with the CINERAMA trial, La Furia Roja looks to repeat with the ROTATE-3 study. Spain has had an easy time in this year's Tournament, having faced competitive teams and making easy work of them. That's the power that SGLT2i and mineralocorticoid receptor antagonists (MRAs) have on the collective CVRM psyche.
It's the Danes against La Furia Roja for the NephroWorldCup Championship. Cast your vote here.
Brasil: Balanced solutions in critically ill patients
Brasil: Balanced solutions in critically ill patients
England: IV iron to reduce MI in HD patients
England: IV iron to reduce MI in HD patients
Brasil finds itself in a tough position. Having lost to an SGLT2i team, it now faces The Three Lions and their look at reducing MIs in HD patients using iron therapy in the bronze match. Will this be the chance for balanced solutions to captivate the CVRM community?
England is coming off a catastrophic defeat to Denmark in the Semifinals. Will it regain its form as a hidden gem for CVRM enthusiasts? Will The Three Lions make this a purely European Tournament this year?
Google Sites
Report abuse